|
 |
 |
Oct 2005 |
| Newsletter | ||
Gabor Heltovics, Business Development Director and Dr. Peter Krajcsi, Chief Scientific Officer at SOLVO Biotechnology would like to invite to visit us at our booth N°212 at the 13th NA ISSX Meeting, 20th JSSX Meeting in Maui, Hawaii, from October 23-27. There you can also meet Dr. Peter A. Csikos, Business Development Manager and Glavinas Hristos, Principal Scientist, who will also hold a presentation entitled "New in vitro assays for the detection of the interaction of test drugs with the BCRP (ABCG2) transporter using the ATPase assay" at the meeting.
The lecture will take place on Tuesday, October 25th, from 3:30 pm, during the Infomercial Session A, in the Lokelani Ballroom.
It would be our great pleasure to discuss how our membrane transporter technologies can support your drug discovery and development efforts.
We are very much looking forward to meeting you in Hawaii!
Dear SOLVO Customer:
We are happy to announce that In Vitro Technologies, Inc. (IVT) and SOLVO Biotechnologies Inc.
entered to a Distribution Agreement for Solvo's in vitro ABC Membrane Transporter Assay Products.
From now on, IVT distributes Solvo's Membrane Transporter Assay products on the North American
(US & Canada) market.
In Vitro Technologies, Inc. is a recognized leader in providing quality in vitro products and services, particularly for ADME-Tox research applications. Continuing with IVT's commitment to bring an extensive line of solutions for drug discovery and development research, IVT and SOLVO have collaborated to leverage IVT's strength in the marketplace and SOLVO's innovative Membrane Transporter products. "We are very excited about this partnership with SOLVO and firmly believe that it will deliver additional value to pharmaceutical research customers in North America. By making the products available from with in the United States, we are making the purchase process efficient and cost-effective coupled with increased ability to provide technical support." said Dr. Paul Silber, President and CEO of IVT.
"By now, it is common knowledge among researchers that ABC transporters play a key role in the function of the blood-brain barrier (BBB), blood-CSF barrier, blood-testis barrier, intestinal epithelia (absorption), airway epithelia, liver epithelia and the kidney epithelia, " explained Gábor Heltovics, SOLVO's Business Development Director. "SOLVO's leading in vitro assay systems are designed to detect interaction of test compounds with a wide array of ABC Transporter proteins found at these vital pharmacological barriers. Our products are widely used for in vitro ADME/Tox, DMPK, oncology drug research and multi-drug resistant (MDR) modulating agent discovery. We are very excited about the opportunity to work with In Vitro Technologies, Inc. as an ideal partner to further expand the usage of our products".
SOLVO's unique technology platform is built on the following core capabilities:
In North America, for technical and order information in the future, please contact your IVT customer service representative or email to: customerservice@invitrotech.com - You can also call IVT on 1-888-488-3232 (toll-free)
Best regards,
SOLVO Biotechnology Business Development Team
|
For Customers in Japan:
Funakoshi (distributor of SOLVO membrane products)
Iwaki (exclusive distributor of SOLVO Fee-for Service Screenings, distributor of SOLVO membrane products)
|
| Privileged/confidential information may be contained in this message. This communication is confidential and intended solely for the addressee(s). Unauthorized distribution, modification or disclosure of the contents may be unlawful. If you receive this in error, please notify the sender and delete it from your system. If you are not the addressee indicated in this message (or responsible for delivery of the message to such person), you may not copy or deliver this message to anyone. |
If you wish to
unsubscribe, please send a letter to 
with 'unsubscribe' in the subject field. |